US medtech group issues guiding principles for device DTC ads
This article was originally published in SRA
Executive Summary
US medtech industry association AdvaMed has for the first time issued a set of voluntary guiding principles for the direct-to-consumer advertising of medical devices1,2. The 13 guiding principles, which are designed to ensure that DTC advertising for devices provides the most accurate and meaningful information for patients, “set a high bar” for the responsible use of DTC advertising by device companies, says AdvaMed.
You may also be interested in...
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.